Conservative management of endometrial stromal sarcoma at stage III: A case report

por DONG, RUIYING, MAO, HONGLUAN, ZHANG, PEIHAI
Publicado 2014

Successful pregnancy following conservative management of low-grade endometrial stromal sarcoma: A case report

por DONG, RUIYING, PANG, YINGXIN, MAO, HONGLUAN, YANG, NING, LIU, PEISHU
Publicado 2014

Development of Nomogram Models Based on Peripheral Blood Score and Clinicopathological Parameters to Predict Preoperative Advanced Stage and Prognosis for Epithelial Ovarian Cancer...

por Bai, Gaigai, Zhou, Yue, Rong, Qing, Qiao, Sijing, Mao, Hongluan, Liu, Peishu
Publicado 2023

MiR-519d represses ovarian cancer cell proliferation and enhances cisplatin-mediated cytotoxicity in vitro by targeting XIAP

por Pang, Yingxin, Mao, Hongluan, Shen, Liang, Zhao, Zhe, Liu, Ruihan, Liu, Peishu
Publicado 2014

Novel Nanocomplexes Targeting STAT3 Demonstrate Promising Anti-Ovarian Cancer Effects in vivo

por Zhang, Xiaolei, Lu, Tao, Ma, Yanhui, Li, Rui, Pang, Yingxin, Mao, Hongluan, Liu, Peishu
Publicado 2020

Identification of Three Potential Prognostic Genes in Platinum-Resistant Ovarian Cancer via Integrated Bioinformatics Analysis

por Zhang, Xue, Wei, Xuan, Bai, Gaigai, Huang, Xueyao, Hu, Shunxue, Mao, Hongluan, Liu, Peishu
Publicado 2021

The gene signature of tertiary lymphoid structures within ovarian cancer predicts the prognosis and immunotherapy benefit

por Hou, Yue, Qiao, Sijing, Li, Miao, Han, Xue, Wei, Xuan, Pang, Yingxin, Mao, Hongluan
Publicado 2023

ROR2 induces cell apoptosis via activating IRE1α/JNK/CHOP pathway in high-grade serous ovarian carcinoma in vitro and in vivo

por Li, Rui, Liu, Tianfeng, Shi, Juanjuan, Luan, Wenqing, Wei, Xuan, Yu, Jiangtao, Mao, Hongluan, Liu, Peishu
Publicado 2019

Low Density Lipoprotein Receptor (LDLR) and 3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase (HMGCR) Expression are Associated with Platinum-Resistance and Prognosis in Ovarian Carc...

por Huang, Xueyao, Wei, Xuan, Qiao, Sijing, Zhang, Xue, Li, Rui, Hu, Shunxue, Mao, Hongluan, Liu, Peishu
Publicado 2021

Emodin suppresses proliferation, migration and invasion in ovarian cancer cells by down regulating ILK in vitro and in vivo

por Lu, Jingjing, Xu, Ying, Zhao, Zhe, Ke, Xiaoning, Wei, Xuan, Kang, Jia, Zong, Xuan, Mao, Hongluan, Liu, Peishu
Publicado 2017

Akt/mTOR-Mediated Autophagy Confers Resistance To BET Inhibitor JQ1 In Ovarian Cancer

por Luan, Wenqing, Pang, Yingxin, Li, Rui, Wei, Xuan, Jiao, Xiaoxiao, Shi, Juanjuan, Yu, Jiangtao, Mao, Hongluan, Liu, Peishu
Publicado 2019

Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K–AKT Pathway and Activating the AMPK–ROS Pathway

por Wei, Xuan, Shi, Juanjuan, Lin, Qianhan, Ma, Xiaoxue, Pang, Yingxin, Mao, Hongluan, Li, Rui, Lu, Wei, Wang, Yu, Liu, Peishu
Publicado 2021

GABPA Expression in Endometrial Carcinoma: A Prognostic Marker

por Ma, Xiaoxue, Lin, Qianhan, Cui, Gongting, Zhao, Jing, Wei, Xuan, Li, Rui, Mao, Hongluan, Ma, Yanhui, Liu, Peishu, Pang, Yingxin
Publicado 2021

Corrigendum: Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K–AKT Pathway and Activating the AMPK–ROS Pathway

por Wei, Xuan, Shi, Juanjuan, Lin, Qianhan, Ma, Xiaoxue, Pang, Yingxin, Mao, Hongluan, Li, Rui, Lu, Wei, Wang, Yu, Liu, Peishu
Publicado 2021

The BRD4 inhibitor JQ1 suppresses tumor growth by reducing c-Myc expression in endometrial cancer

por Pang, Yingxin, Bai, Gaigai, Zhao, Jing, Wei, Xuan, Li, Rui, Li, Jie, Hu, Shunxue, Peng, Lu, Liu, Peishu, Mao, Hongluan
Publicado 2022